Personalized medicine applied to patients with complex diseases, like cancer, grants a better quality of life and longer survival. However, in most instances it is not curative, due to the onset of two main obstacles represented by undesired toxicity and/or drug resistance, which contribute to a different extent depending upon the inhibition mechanism. In this short commentary, we try to combine the idea of multi-targeting agents with an Artificial Intelligence platform to further improve patients’ treatment and allowing them to be cured or live essentially disease-free. (Figure presented)
Of magic bullets, multiple targets, and artificial intelligence. Are we all set to defeat cancer?
Sissi C.
2022
Abstract
Personalized medicine applied to patients with complex diseases, like cancer, grants a better quality of life and longer survival. However, in most instances it is not curative, due to the onset of two main obstacles represented by undesired toxicity and/or drug resistance, which contribute to a different extent depending upon the inhibition mechanism. In this short commentary, we try to combine the idea of multi-targeting agents with an Artificial Intelligence platform to further improve patients’ treatment and allowing them to be cured or live essentially disease-free. (Figure presented)File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
GC-11674WR published mainmanuscript.pdf
accesso aperto
Tipologia:
Published (publisher's version)
Licenza:
Creative commons
Dimensione
677.84 kB
Formato
Adobe PDF
|
677.84 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.